profit from every $100 of sales.
$0$100
Lumexa Imaging Holdings
$15.95+14.58% today
-13.9% in 1 year
1-year low $6.771-year high $18.53
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2023 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Lumexa Imaging Holdings sold, what it kept, and what it did with the cash.
Sales went from $936 million in 2023 to $1.02 billion in 2025, with -$47.1 million of profit last year.
SalesProfit
Lumexa Imaging Holdings vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Lumexa Imaging Holdings | No profit yet | ||
 Boston Scientific | 22.6× · Fair price | ||
 Koninklijke Philips | 29.7× · Fair price | ||
 Steris | 31.8× · Expensive | ||
 Zimmer Biomet Holdings | 28.8× · Fair price |
AI analysis
An AI analyst reads Lumexa Imaging Holdings's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2023 | 2024 | 2025 |
|---|---|---|---|
| 936 | 949 | 1,023 | |
| 99 | 96 | 158 | |
| -13 | -16 | 27 | |
| 95 | 114 | 142 | |
| -122 | -94 | -47 | |
| -1.76 | -1.35 | -0.66 | |
| 10.6% | 10.1% | 15.4% | |
| -1.4% | -1.7% | 2.6% | |
| -13.1% | -9.9% | -4.6% |
Balance sheet
| In millions of USD | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total assets | 1,672 | 1,671 | 1,765 |
| Cash | 20 | 26 | 59 |
| Total debt | 1,305 | 1,309 | 963 |
| Total liabilities | 1,473 | 1,509 | 1,178 |
| 198 | 162 | 586 | |
| 69 | 95 | 71 | |
| 1.2% | 3.1% | 4.4% | |
| -61.6% | -58.2% | -8.0% |
Cash flow
| In millions of USD | 2023 | 2024 | 2025 |
|---|---|---|---|
| 38 | 41 | 17 | |
| 24 | 28 | 23 | |
| 14 | 13 | -6 | |
| Dividends paid | – | – | – |
| 0 | 0 | 0 | |
| 55 | 57 | 42 |
Valuation
- –
- 21.8×
- –
- 1.2×
- 1.5×
- –
- 17.2×
- -0.4%
- -3.1%
- 0.0%
Profitability
- 15.4%
- 2.6%
- -4.6%
- 6.8%
- 0.7%
- -5.9%
- -15.4%
- -3.0%
- 0.8%
- –
Growth
- +4.6%
- –
- −149.4%
- –
- −13.4%
Financial health
- 17.5×
- 1.61
- 54.9%
- 0.2×
- 1.40
- 1.40
- 0.44
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 35%of 958
Bottom 32%of 889
Bottom 28%of 890
Bottom 35%of 987
What analysts expect
- Average price target
- $21.43
- Range
- $15.00 – $23.00
- 1 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 12, 2026 | 0.18 | 0.12 | +50.0% |
| Mar 26, 2026 | -0.66 | 0.05 | −1,420.0% |
| Dec 3, 2025 | -0.03 | – | – |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
17No pass
Benjamin Graham
40No pass
Philip Fisher
20No pass
Peter Lynch
21No pass
Joel Greenblatt
3No pass
Charlie Munger
16No pass
Terry Smith
12No pass
Questions about Lumexa Imaging Holdings
Is Lumexa Imaging Holdings a good stock to buy?
A business with weak numbers that is not profitable yet. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Lumexa Imaging Holdings AI analysis
What does Lumexa Imaging Holdings do?
Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. It is in Medical - Devices.
Does Lumexa Imaging Holdings pay a dividend?
No. Lumexa Imaging Holdings does not pay a dividend at the moment.
Is Lumexa Imaging Holdings stock halal?
No. Lumexa Imaging Holdings does not pass our halal screen: its debt is 63% of its market value, at or above the 33% limit. How we check
How has Lumexa Imaging Holdings stock done over the past year?
Down 13.9% over the past twelve months, to $15.95. It traded between $6.77 and $18.53 and is 13.9% below its high.
Who are Lumexa Imaging Holdings's competitors?
The largest listed companies in the same industry are Boston Scientific, Koninklijke Philips, Steris and Zimmer Biomet Holdings. The peers table on this page compares their profit, growth and price with Lumexa Imaging Holdings's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.